| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
2007-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d7973bd26a60fa2b7d2ff2752ec595a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383741d446db5d03df44ab8e772542b2 |
| publicationDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010129425-A1 |
| titleOfInvention |
Vaginal delivery system for mirtazapine |
| abstract |
This invention relates to an extended release formulation comprising solid mirtazapine, which formulation is a vaginal device having a skin and which device comprises an inner compartment made of a thermoplastic polymer, which polymer is containing mirtazapine. The polymer is preferably made of ethylene-vinyl acetate copolymer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9427400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010104619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137031-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603272-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11259956-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4218855-A2 |
| priorityDate |
2006-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |